Lv2
106 积分 2021-02-07 加入
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update
2天前
已完结
Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective Cohort
2天前
待确认
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
2天前
已完结
Personalized MRD Assessment in Peri-surgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma
3天前
已完结
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 Update
6天前
已完结
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
6天前
已完结
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
10天前
已完结
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial
10天前
已完结
Plasma ctDNA as a treatment response biomarker in metastatic cancers: evaluation by the RECIST working group
10天前
已完结
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
11天前
已完结
皖公网安备34019202002308
